Abstract: There is provided a computer-implemented method for updating a search distribution of an evolutionary strategies optimizer using an optimizer neural network comprising one or more attention blocks. The method comprises receiving a plurality of candidate solutions, one or more parameters defining the search distribution that the plurality of candidate solutions are sampled from, and fitness score data indicating a fitness of each respective candidate solution of the plurality of candidate solutions. The method further comprises processing, by the one or more attention neural network blocks, the fitness score data using an attention mechanism to generate respective recombination weights corresponding to each respective candidate solution. The method further comprises updating the one or more parameters defining the search distribution based upon the recombination weights applied to the plurality of candidate solutions.

Abstract: An access point (AP) station (STA) (AP STA) that is part of an AP multi-link device (MLD) may be configured as a reporting AP may encode a BSS Transition Management (BTM) request frame for transmission to one or more associated non-AP stations (STAs). The BTM request frame may include a neighbor report element encoded to include information about one or more neighbor APs. The neighbor report element may indicate whether the one or more neighbor APs identified in the neighbor report element are part of an AP MLD and, when a neighbor AP is indicated to be part of an AP MLD whether the reporting AP is part of the indicated AP MLD. The AP STA may decode a reassociation frame from one of the non-AP STAs for transition from one of the AP STAs of the AP MLD to one of the neighbor APs.

Abstract: Provided are methods and compositions comprising antibodies capable of specific binding to human CEACAM1 molecules, for treating and diagnosing cancer as well as assessing CEACAM1 expression in tumor infiltrating immune cells (TILs) in a biological sample obtained from a [cancer] subject.

Abstract: This disclosure describes systems, methods, and devices related to high throughput (HT) control information. A device may determine a frame comprising HT control information. The device may determine to extend a size of the HT control information. The device may cause to generate a management or data frame for sending to a first station device of one or more station devices, the management or data frame comprising extended high throughput (HT) control information, define a new control identification (ID) associated with the extended HT control information, and cause to send the management or data frame to the first station device.

Abstract: Ice recrystallization inhibitor (IRI) compounds and methods for cryopreserving umbilical cord blood are provided. The compounds are unsubstituted, mono-substituted, or di-substituted aryl-aldonamides. The methods include fractionating whole umbilical cord blood to generate a fraction comprising hematopoietic stem cells, mixing the hematopoietic stem cells with at least one IRI compound to form an IRI suspension, and freezing the IRI suspension.

Abstract: The invention relates to small molecule ice recrystallization inhibitor (IRI) compounds having increased ice recrystallization inhibition activity. The IRI compounds disclosed herein are useful in compositions, kits and methods for cryopreserving biological material such as organs, tissues and cells.

Abstract: Ice recrystallization inhibitor (IRI) compounds and methods for cryopreserving umbilical cord blood are provided. The compounds are unsubstituted, mono-substituted, or di-substituted aryl-adlonamides. The methods include fractionating whole umbilical cord blood to generate a fraction comprising hematopoietic stem cells, mixing the hematopoietic stem cells with at least one IRI compound to form an IRI suspension, and freezing the IRI suspension.

Abstract: The invention relates to small molecule ice recrystallization inhibitor (IRI) compounds having increased ice recrystallization inhibition activity. The IRI compounds disclosed herein are useful in compositions, kits and methods for cryopreserving biological material such as organs, tissues and cells.